Healthcare Global (HCG) | Financial Analysis & Statements
Healthcare Global Enterprises Ltd. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
6.3B
Gross Profit
3.2B
49.98%
Operating Income
489.6M
7.76%
Net Income
-79.0M
-1.25%
EPS (Diluted)
₹-0.68
Balance Sheet Metrics
Total Assets
35.4B
Total Liabilities
25.5B
Shareholders Equity
9.9B
Debt to Equity
2.58
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Healthcare Global Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 22.0B | 18.9B | 16.8B | 13.8B | 10.0B |
| Cost of Goods Sold | 10.8B | 9.1B | 8.0B | 6.8B | 5.0B |
| Gross Profit | 11.2B | 9.8B | 8.8B | 7.0B | 5.0B |
| Gross Margin % | 50.8% | 51.9% | 52.3% | 50.7% | 50.2% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 1.1B | 1.1B | 1.0B | 604.9M | 412.0M |
| Other Operating Expenses | 2.5B | 2.3B | 1.8B | 1.8B | 1.4B |
| Total Operating Expenses | 3.6B | 3.4B | 2.8B | 2.4B | 1.9B |
| Operating Income | 1.9B | 1.6B | 1.7B | 774.4M | -325.8M |
| Operating Margin % | 8.5% | 8.3% | 9.9% | 5.6% | -3.2% |
| Non-Operating Items | |||||
| Interest Income | 158.8M | 127.0M | 118.1M | 115.6M | 156.1M |
| Interest Expense | 1.5B | 994.5M | 914.7M | 838.9M | 1.1B |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 569.6M | 677.3M | 448.8M | 877.7M | -2.3B |
| Income Tax | 81.3M | 264.0M | 272.5M | 488.5M | -75.6M |
| Effective Tax Rate % | 14.3% | 39.0% | 60.7% | 55.7% | 0.0% |
| Net Income | 488.3M | 413.3M | 176.3M | 389.2M | -2.2B |
| Net Margin % | 2.2% | 2.2% | 1.1% | 2.8% | -22.0% |
| Key Metrics | |||||
| EBITDA | 4.2B | 3.4B | 3.3B | 2.4B | 1.2B |
| EPS (Basic) | ₹3.17 | ₹3.46 | ₹2.11 | ₹4.14 | ₹-17.02 |
| EPS (Diluted) | ₹3.12 | ₹3.43 | ₹2.10 | ₹3.97 | ₹-17.02 |
| Basic Shares Outstanding | 140243466 | 139237131 | 139073790 | 129707612 | 113648953 |
| Diluted Shares Outstanding | 140243466 | 139237131 | 139073790 | 129707612 | 113648953 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Healthcare Global Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 2.4B | 2.7B | 1.7B | 2.0B | 300.0M |
| Short-term Investments | 40.0K | 372.4M | 292.3M | 66.4M | 1.4B |
| Accounts Receivable | 4.0B | 2.9B | 3.0B | 2.2B | 1.9B |
| Inventory | 530.2M | 426.7M | 382.9M | 299.7M | 211.1M |
| Other Current Assets | 345.0M | 313.6M | 339.2M | 216.8M | 224.7M |
| Total Current Assets | 8.4B | 6.8B | 5.8B | 5.0B | 4.3B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 934.7M | 673.5M | 533.6M | 435.6M | 400.4M |
| Goodwill | 9.3B | 4.9B | 3.8B | 3.9B | 2.1B |
| Intangible Assets | 655.2M | 466.9M | 187.0M | 298.0M | 214.9M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | -240.0K | -240.0K | -251.0K | 331.1M | -10.0K |
| Total Non-Current Assets | 27.0B | 20.3B | 17.4B | 17.2B | 16.0B |
| Total Assets | 35.4B | 27.1B | 23.2B | 22.2B | 20.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 3.3B | 2.8B | 2.5B | 1.9B | 1.5B |
| Short-term Debt | 4.6B | 2.3B | 864.0M | 859.0M | 1.6B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 367.0M | 39.8M | 755.1M | 785.0M | 626.2M |
| Total Current Liabilities | 10.5B | 7.4B | 5.7B | 4.7B | 4.7B |
| Non-Current Liabilities | |||||
| Long-term Debt | 13.8B | 10.4B | 8.1B | 8.3B | 8.2B |
| Deferred Tax Liabilities | 35.4M | 60.8M | 123.7M | 12.8M | 42.8M |
| Other Non-Current Liabilities | -30.0K | 328.2M | 359.3M | 255.0M | 279.8M |
| Total Non-Current Liabilities | 15.1B | 11.0B | 8.8B | 8.7B | 8.6B |
| Total Liabilities | 25.5B | 18.4B | 14.5B | 13.4B | 13.2B |
| Equity | |||||
| Common Stock | 1.4B | 1.4B | 1.4B | 1.4B | 1.3B |
| Retained Earnings | -4.1B | -5.0B | -4.5B | -4.4B | -4.8B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 9.9B | 8.7B | 8.7B | 8.8B | 7.1B |
| Key Metrics | |||||
| Total Debt | 18.4B | 12.7B | 9.0B | 9.1B | 9.8B |
| Working Capital | -2.0B | -638.5M | 100.2M | 325.9M | -302.9M |
Balance Sheet Composition
Healthcare Global Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 569.6M | 677.3M | 448.8M | 877.7M | -2.3B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 65.4M | 78.5M | 65.1M | 31.0M | 19.1M |
| Working Capital Changes | -1.1B | -396.9M | -1.0B | -575.0M | -590.0K |
| Operating Cash Flow | 824.3M | 1.2B | 302.1M | 185.6M | -366.9M |
| Investing Activities | |||||
| Capital Expenditures | -2.1B | -1.8B | -1.3B | -704.4M | -353.6M |
| Acquisitions | -2.0B | -450.0M | 0 | 379.9M | -52.5M |
| Investment Purchases | -1.2B | -265.7M | -634.1M | -824.0M | 0 |
| Investment Sales | 252.2M | 251.4M | 501.9M | 2.3B | - |
| Investing Cash Flow | -5.0B | -2.3B | -1.4B | 1.1B | -1.8B |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 2.2B | 2.9B | 554.3M | 1.7B | 140.6M |
| Debt Repayment | -817.6M | -1.5B | -627.6M | -3.5B | -2.6B |
| Financing Cash Flow | 1.4B | 986.3M | -55.4M | -860.6M | 2.3B |
| Free Cash Flow | 1.1B | 989.0M | 1.2B | 1.5B | 851.0M |
| Net Change in Cash | -2.8B | -155.6M | -1.1B | 433.9M | 148.2M |
Cash Flow Trend
Healthcare Global Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
438.11
Forward P/E
61.80
Price to Book
8.81
Price to Sales
3.48
PEG Ratio
-1.86
Profitability Ratios
Profit Margin
0.77%
Operating Margin
7.73%
Return on Equity
4.49%
Return on Assets
1.25%
Financial Health
Current Ratio
0.73
Debt to Equity
177.91
Beta
-0.24
Per Share Data
EPS (TTM)
₹1.32
Book Value per Share
₹65.64
Revenue per Share
₹175.86
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| HCG | 85.1B | 438.11 | 8.81 | 4.49% | 0.77% | 177.91 |
| Apollo Hospitals | 1.1T | 61.08 | 12.11 | 16.71% | 7.44% | 83.61 |
| Max Healthcare | 979.8B | 68.81 | 9.77 | 11.47% | 17.43% | 32.58 |
| Rainbow Children's | 128.6B | 50.33 | 8.50 | 16.50% | 15.97% | 53.24 |
| Jupiter Life Line | 82.8B | 43.84 | 5.71 | 14.27% | 13.45% | 27.81 |
| Yatharth Hospital | 69.2B | 43.38 | 4.31 | 7.97% | 15.29% | 1.53 |
Financial data is updated regularly. All figures are in the company's reporting currency.





